Sign in
MDT-MEDTRONIC PLC
Medtronic Gears Up for Market Impact with Launch of Evolut FX+ TAVR Device and New Clinical Trials
Member Only Article
Monday
28 October, 2024
Medtronic is set to make waves in the medtech arena with the launch of its Evolut FX+ TAVR system, designed to enhance patient care for severe aortic stenosis. As the competition heats up, can Medtronic maintain its edge and navigate the evolving landscape effectively?
Article Impact Score
0
50
100
Underperform
Bearish
Neutral
Bullish
Outperform
0
Key Takeaways
- Loading...
Most Read
Join Foliko Premium!
Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.
Go Premium - 7 Day Free Trial